Your browser doesn't support javascript.
loading
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study).
Van der Weijst, Lotte; Aguado-Barrera, Miguel E; Azria, David; Berkovic, Patrick; Boisselier, Pierre; Briers, Erik; Bultijnck, Renée; Calvo-Crespo, Patricia; Chang-Claude, Jenny; Choudhury, Ananya; Defraene, Gilles; Demontois, Sylvian; Dunning, Alison M; Elliott, Rebecca M; Ennis, Dawn; Faivre-Finn, Corinne; Franceschini, Marzia; Gutiérrez-Enríquez, Sara; Herskind, Carsten; Higginson, Daniel S; Kerns, Sarah L; Johnson, Kerstie; Mollà, Meritxell; Lambrecht, Maarten; Ramos, Mónica; Rancati, Tiziana; Rimner, Andreas; Rosenstein, Barry S; De Ruysscher, Dirk; Salem, Ahmed; Sangalli, Claudia; Seibold, Petra; Sosa-Fajardo, Paloma; Sperk, Elena; Stobart, Hilary; Summersgill, Holly; Surmont, Veerle; Symonds, Paul; Taboada-Lorenzo, Begoña; Talbot, Christopher J; Valdagni, Riccardo; Vega, Ana; Veldeman, Liv; Veldwijk, Marlon R; Ward, Tim; Webb, Adam; West, Catharine M L; Lievens, Yolande.
Afiliación
  • Van der Weijst L; Department of Radiation Oncology, Ghent University Hospital and Ghent University, Ghent, Belgium. Electronic address: Lotte.vanderweijst@ugent.be.
  • Aguado-Barrera ME; Fundación Pública Galega de Medicina Xenómica, Grupo de Medicina Xenómica (USC), Santiago de Compostela, Spain.
  • Azria D; Federation Universitaire d'oncologie radiothérapie d'Occitanie Méditerranée, Univ Montpellier, IRCM Inserm U1194, ICM, Montpellier, France.
  • Berkovic P; Department of radiotherapy-oncology, Leuvens Kanker Instituut, UZ Leuven, Leuven, Belgium.
  • Boisselier P; Federation Universitaire d'oncologie radiothérapie d'Occitanie Méditerranée, Univ Montpellier, IRCM Inserm U1194, ICM, Montpellier, France.
  • Briers E; Patient Advocat, Hasselt, Belgium.
  • Bultijnck R; Department of Radiation Oncology, Ghent University Hospital and Ghent University, Ghent, Belgium; Research Foundation - Flanders (FWO), Brussels, Belgium.
  • Calvo-Crespo P; Department of Radiation Oncology, Hospital Clínico Universitario de Santiago, SERGAS, Instituto de Investigación Sanitaria de Santiago de Compostela, Spain.
  • Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Germany.
  • Choudhury A; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, United Kingdom.
  • Defraene G; Laboratory of Experimental Radiotherapy, Department of Oncology, KULEUVEN, Leuven, Belgium.
  • Demontois S; Federation Universitaire d'oncologie radiothérapie d'Occitanie Méditerranée, Univ Montpellier, IRCM Inserm U1194, ICM, Montpellier, France.
  • Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Research Labs, United Kingdom.
  • Elliott RM; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, United Kingdom.
  • Ennis D; Royal Derby Hospital, Derby DE22 3NE, United Kingdom.
  • Faivre-Finn C; University of Manchester, The Christie NHS Foundation Trust, United Kingdom.
  • Franceschini M; Unit of Radiation Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Gutiérrez-Enríquez S; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Herskind C; Department of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Higginson DS; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, United States.
  • Kerns SL; Departments of Radiation Oncology and Surgery, University of Rochester Medical Center, Rochester, New York, NY, United States.
  • Johnson K; Leicester Cancer Research Centre, University of Leicester, Leicester LE1 7RH, United Kingdom.
  • Mollà M; Radiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Lambrecht M; Department of radiotherapy-oncology, Leuvens Kanker Instituut, UZ Leuven, Leuven, Belgium.
  • Ramos M; Radiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Rancati T; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Rimner A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, United States.
  • Rosenstein BS; Department of Radiation Oncology, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, United States.
  • De Ruysscher D; Department of Radiation Oncology (Maastro), Maastricht University Medical Center, GROW School for Oncology and Developmental Biology, Maastricht, the Netherlands.
  • Salem A; University of Manchester, The Christie NHS Foundation Trust, United Kingdom.
  • Sangalli C; Unit of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sosa-Fajardo P; Department of Radiation Oncology, Hospital Clínico Universitario de Santiago, SERGAS, Instituto de Investigación Sanitaria de Santiago de Compostela, Spain.
  • Sperk E; Department of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Stobart H; Independent Cancer Patients' Voice, United Kingdom.
  • Summersgill H; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, United Kingdom.
  • Surmont V; Department of Respiratory Medicine, Ghent University Hospital and Ghent University, Ghent, Belgium.
  • Symonds P; Leicester Cancer Research Centre, University of Leicester, Leicester LE1 7RH, United Kingdom.
  • Taboada-Lorenzo B; Department of Radiation Oncology, Hospital Clínico Universitario de Santiago, SERGAS, Instituto de Investigación Sanitaria de Santiago de Compostela, Spain.
  • Talbot CJ; Leicester Cancer Research Centre, University of Leicester, Leicester LE1 7RH, United Kingdom.
  • Valdagni R; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Unit of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Dept. of Oncology and Hemato-oncology, Università degli Studi di Mlano, Milan, Italy.
  • Vega A; Fundación Pública Galega de Medicina Xenómica, Grupo de Medicina Xenómica (USC), Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela, Biomedical Network on Rare Diseases (CIBERER), Spain.
  • Veldeman L; Department of Radiation Oncology, Ghent University Hospital and Ghent University, Ghent, Belgium.
  • Veldwijk MR; Department of Radiation Oncology, Universitätsklinikum Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Ward T; Trustee Pelvic Radiation Disease Association, NCRI CTRad Consumer, United Kingdom.
  • Webb A; Department of Genetics and Genome Biology, University of Leicester, United Kingdom.
  • West CML; Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, United Kingdom.
  • Lievens Y; Department of Radiation Oncology, Ghent University Hospital and Ghent University, Ghent, Belgium.
Lung Cancer ; 166: 228-241, 2022 04.
Article en En | MEDLINE | ID: mdl-35334417
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Traumatismos por Radiación / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Traumatismos por Radiación / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article